• S&P 500: 1,351.95
  • Change: 0.00%
$18.88 0.00 (0%)
2/9/2012 4:00 PM

Seattle Genetics, Inc. (NASDAQ:SGEN)

CAPS Rating: 3 out of 5

A biotechnology company, which develops monoclonal antibody-based therapies for the treatment of cancer and autoimmune diseases.

Current Price $18.88 Mkt Cap $2.17B
Open $0.00 P/E Ratio 0.00
Prev. Close $19.01 Div. (Yield) N/A (N/A)
Daily Range $18.72 - $19.12 Volume 863,915
52-Wk Range $12.29 - $22.40 Avg. Daily Vol. 0

News & Discussion Boards

Caps

How do you think SGEN will perform against the market?

You must Sign in to MSN Caps before you can make a call.

All Players

350 Outperform
33 Underperform
 

All-Star Players

86 Outperform
13 Underperform
 

Wall Street

9 Outperform
6 Underperform
 

Top SGEN Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

irishred1 (62.38)
Submitted March 20, 2011

unique antibody drug conjugate technology with many big pharma partnerships...first candidate about to gain approval if the FDA isn't phased by the single arm trial design. I see nothing but upside long term

Add Comment | Reply | Report this Post

PDTBiotech (92.44)
Submitted July 07, 2011

$2.34B for a drug which treats HL and ALCL seems very, very rich, even when taking SGEN's strong balance sheet into account. Very cool platform, but the target for brentuximab vedotin is expressed on a narrow enough set of tumor types to keep this… More

1 Comment | Reply | Report this Post
SGEN VS S&P 500 (SPY)

Fools bullish on SGEN are also bullish on:

Fools bearish on SGEN are also bearish on:

Recent Community Commentary

Read the most recent pitches from players about SGEN.

Recs

0
Member Avatar MDmomma (< 20) Submitted: 2/8/2012 3:40:53 PM : Outperform Start Price: $18.97 SGEN Score: -0.71

proprietary methods for linking antibody to cytotoxic drugs has potential to revolutionize chemotherapy

Report this Post Add Comment | Reply | Permalink

Recs

0
Member Avatar kblumbio (< 20) Submitted: 9/9/2011 4:43:05 PM : Outperform Start Price: $17.14 SGEN Score: -8.10

Best ADC platform, approved product!

Report this Post Add Comment | Reply | Permalink

Recs

0
Member Avatar Kdixon7959 (< 20) Submitted: 8/26/2011 10:49:47 PM : Outperform Start Price: $15.95 SGEN Score: +9.91

Great pipeline of products

Report this Post Add Comment | Reply | Permalink
View All 65 Pitches »

Leaderboard

Find the members with the highest scoring picks in SGEN.

Score Leader

lloydvon

lloydvon (85.23) Score: +311.16

The Score Leader is the player with the highest score across all their picks in SGEN.

Top
Pick 		Member Name Member
Rating 		Start
Date 		Call Time
Frame 		Start
Price 		Stock
Gain 		Index
Gain 		Score Commentary
lloydvon 85.23 8/30/2006 Outperform 1Y $4.48 +321.43% +10.27% +311.16 1 Comment
Zipsdad < 20 10/4/2006 Outperform 1Y $4.67 +304.28% +8.05% +296.24 0 Comment
twildstar 87.70 10/11/2006 11/11/2006 Outperform 5Y $4.93 +282.96% +5.93% +277.03 0 Comment
vkowalczuk 72.48 10/19/2006 Outperform 1Y $5.10 +270.20% +5.38% +264.82 1 Comment
RAIDERFAN77 70.06 1/3/2007 7/1/2009 Outperform 1Y $5.27 +258.25% +1.00% +257.25 0 Comment
SloopJohnB06 72.08 12/26/2006 Outperform 5Y $5.63 +235.35% +2.03% +233.31 0 Comment
muae1 < 20 12/18/2006 Outperform NS $5.76 +227.78% +0.79% +226.99 0 Comment
biogirl < 20 1/8/2007 Outperform 3M $6.45 +192.76% +2.13% +190.63 0 Comment
opveiby 84.74 1/8/2007 Outperform 1Y $6.46 +192.26% +2.11% +190.15 0 Comment
Turkmenbashi 51.16 1/8/2007 Outperform 3Y $6.59 +186.49% +1.78% +184.72 0 Comment
View Complete Scorecard »

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Player Name Player
Rating		 Start
Date		 Call Time
Frame		 Start
Price		 Stock
Gain		 S&P
Gain		 Score End Date Commentary
tracksummerstree 73.73 10/5/2011 Underperform NS $19.80 -4.65% +20.19% +24.84 0 Comment
TrackNeedham 92.43 5/6/2011 Outperform NS $16.70 +13.05% +0.31% +12.74 0 Comment
TrackBioLogicEqu 61.88 3/9/2011 Underperform NS $14.79 +27.65% +2.22% -25.43 0 Comment
TrackCanaccord 90.33 11/2/2010 Underperform NS $14.34 +31.66% +13.50% -18.16 0 Comment
TrackBreanMurray 69.41 11/1/2010 Underperform NS $16.04 +17.71% +13.68% -4.02 0 Comment
trackthinkequity 92.04 9/28/2010 Outperform NS $14.49 +30.30% +18.30% +12.00 0 Comment
trackthinkequity 92.04 8/31/2010 Outperform NS $11.61 +4.05% +7.09% -3.04 9/14/2010 @ $12.08 0 Comment
trackwbbsecuriti 39.18 8/4/2010 Underperform NS $12.65 +49.25% +20.29% -28.96 0 Comment
TrackJimCramer 78.02 11/4/2009 Underperform 3W $8.95 +110.95% +29.01% -81.94 0 Comment
TrackDeutscheSec 92.40 8/13/2009 Outperform NS $11.25 +67.82% +36.61% +31.21 0 Comment
TrackOppenheimer 79.30 10/27/2008 Outperform NS $8.28 +128.02% +60.56% +67.46 0 Comment
TrackRBCCapMkts 93.26 3/19/2008 Outperform NS $8.63 +118.77% +5.16% +113.61 0 Comment
TrackMichaelBrus 95.02 2/14/2008 Outperform 1Y $9.35 +101.93% +4.36% +97.56 0 Comment
TrackJPMorgan < 20 1/28/2008 Outperform NS $9.34 +34.90% -10.84% +45.75 4/30/2010 @ $12.60 0 Comment
TrackFortisBank < 20 9/21/2007 Outperform NS $11.79 -17.64% -29.70% +12.06 10/2/2008 @ $9.71 0 Comment
TrackWMBlair 89.85 8/21/2007 Outperform NS $11.03 +71.17% -1.51% +72.68 0 Comment
TrackCarisandCo 88.55 3/8/2007 Outperform NS $7.40 +13.78% -6.58% +20.37 3/13/2008 @ $8.42 0 Comment
TrackRBCCapMkts 93.26 1/9/2007 Outperform NS $6.61 +94.99% +10.50% +84.49 10/15/2007 @ $12.89 0 Comment
TrackBofASec 96.89 12/12/2006 Outperform NS $6.17 +206.00% +1.40% +204.60 0 Comment
TrackNeedham 92.43 10/25/2006 Outperform NS $4.92 +210.16% -3.55% +213.71 3/31/2011 @ $15.26 0 Comment
TrackNextGen 89.84 10/6/2006 Outperform NS $4.95 +281.41% +6.53% +274.89 0 Comment

Featured Broker Partners